From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857.
D000075202:Contraindications; D016208:Databases, Factual; D004348:Drug Labeling; D005515:Food Labeling; D015277:Hotlines; D006801:Humans; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing; D013629:Tamoxifen / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D013629:Tamoxifen